SNYR Company Profile and Key Details

SNYR has shown mixed momentum, losing 0.0% over the past week and -32.71% over the past quarter, though year-to-date performance is down -2.69%. Short-term trend indicators are bullishly aligned (SMA20 -20.71%, SMA50 -26.48%, SMA200 -44.64%). The stock’s 14-day RSI is 27.55 (weak momentum), while the ATR of 0.12 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -68.14% below its high and over 0.0% above its low. Average 10-day trading volume of 776.22 thousand shares is below the 3-month average of 3.48 million, indicating normal recent market interest.

Synergy CHC Corp. has 9.44 million shares outstanding. The public float is 4.05 million shares, elevated short interest at 1.26% of float. This equals 39.49 thousand shares. The short ratio is 0.78 days. Institutional investors hold 34.58% of the float. Insiders own 56.19%.

Wall Street analysts project EPS growth of 28.56% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $7.00 to $3.75. The high target offers 3400.0% upside. The low target suggests 1775.0% downside. The mean target is $5.31. This offers 2555.0% upside. Synergy CHC Corp. earnings surprise history is a mixed track record. The quarter that ended May 14, 2026, missed forecasts by -866.67%. The prior quarter beat by -13600.0%. Over the last six quarters, Apple has recorded several small beats. These include 42.86% in May 15, 2025.

Synergy CHC Corp. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.97. This means the shares are trading below this model’s fair value.

Synergy CHC Corp. (NASDAQ:SNYR) closed at $0.20 USD, losing -$0.01 (-2.97%) from the previous close of $0.20. The stock is currently mid-range between its 52-week high and low $0.18 and $4.00. With a market capitalization of about $2.04 million, Synergy CHC Corp. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.51). Key stats such as the average daily volume over the past year has been around 3.66 million shares, volume is running light vs its 52-week average. Headquartered in Westbrook, ME, Synergy CHC Corp. operates in the Healthcare sector and the Medical - Distribution industry. Led by CEO Jack Ross, the company employs approximately 21 people and listed since March 17, 2014. Synergy CHC Corp. operates as a distributor of diverse consumer health, beauty, and lifestyle merchandise across the United States, Canada, and the United Kingdom.

Synergy CHC Corp. trades at a P/E ratio of -0.14, slightly below the S&P 500 average, with a price-to-sales ratio of 0.07 and a price-to-book ratio of -0.09 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.54, also above market averages.

Our AI price prediction model suggests that Synergy CHC Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -28.57%, with price expected at $0.14 by June 26, 2026, within a range of $0.10 to $0.18 3-Month Outlook: Projected rise of 2.04%, reaching $0.20 by September 10, 2026, with a range of $0.15 to $0.24. 1-Year Outlook: Projected loss of -94.9%, with price at $0.01 by June 11, 2027, within a range of $0.00 to $0.04.

Synergy CHC Corp. (NASDAQ:SNYR) shares are flat -2.69% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Synergy CHC Corp. trading at a premium to the broader market with a P/E of -0.14. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $5.31, suggesting 2609.18% upside. Our AI forecast model points to short-term weakness (-28.57% over two weeks), a medium-term rise (2.04% over three months), and a longer-term loss (-94.9% over one year), with expected trading ranges indicating moderate volatility.